LONG-TERM CANCER-PATIENT SURVIVAL IN THE UNITED-STATES

Citation
Pa. Wingo et al., LONG-TERM CANCER-PATIENT SURVIVAL IN THE UNITED-STATES, Cancer epidemiology, biomarkers & prevention, 7(4), 1998, pp. 271-282
Citations number
30
Categorie Soggetti
Oncology,"Public, Environmental & Occupation Heath
ISSN journal
10559965
Volume
7
Issue
4
Year of publication
1998
Pages
271 - 282
Database
ISI
SICI code
1055-9965(1998)7:4<271:LCSITU>2.0.ZU;2-H
Abstract
Although survival rates are useful for monitoring progress in the earl y detection and treatment of cancer and are of particular interest to patients with new diagnoses, there are limited population-based estima tes of long-term survival rates, We used data collected by the Surveil lance, Epidemiology, and End Results Program for cases diagnosed durin g 1974-1991 and followed through 1992 to estimate relative survival at 5, 10, and 15 years after diagnosis of cancer of the breast, prostate , colon and rectum, and lung, Relative survival after diagnosis of bre ast and prostate cancer continued to decline up through 15 years after diagnosis, whereas survival after diagnosis of lung and colon or rect al cancer remained approximately constant after 5 and 10 years, respec tively, Age-specific patterns of survival varied by site, stage, and d emographics, Among patients with localized breast and prostate cancer, women who were younger than age 45 at breast cancer diagnosis and men who were 75 years and older at prostate cancer diagnosis had the poor est relative survival, Relative survival among lung cancer patients de creased with age at diagnosis, regardless of stage or demographics, an d age-specific patterns of relative survival for patients with cancer of the colon and rectum differed according to race, Among white patien ts diagnosed with cancers of the colon and rectum, relative survival d id not vary by age at diagnosis; among black patients older than 45 at diagnosis, relative survival decreased with age, This study provides population-based estimates of long-term survival and confirms black/wh ite, male/female, and stage-and age-specific differences for the major cancers.